Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sovaldi may be cost-effective, but the U.K. can't afford it, documents say
Sovaldi may be cost-effective, but the U.K. can't afford it, documents say
Sovaldi may be cost-effective, but the U.K. can't afford it, documents say
Submitted by
admin
on October 7, 2014 - 8:09am
Source:
Fierce Pharma
News Tags:
Sovaldi
UK
drug pricing
Gilead Sciences
hepatitis C
Headline:
Sovaldi may be cost-effective, but the U.K. can't afford it, documents say
Do Not Allow Advertisers to Use My Personal information
